# Shenzhen Uni-medica Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-uni-medica-technology-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.uni-medica.com
- Latest round: Series A (Nov 6, 2015)
- Investors on record: 1

## About

Established in 2011 and based in Shenzhen, China, Shenzhen Uni-medica Technology Co., Ltd. is a medical company that provides genetic testing for newborns and children. The company has partnerships with the Chinese Academy of Sciences, Wuhan Institute of Virus Research, Shenzhen University, Hong Kong University, Shenzhen Center for Disease Control and Prevention and Shanghai Children's Hospital.

The company's self-developed products such as high-throughput sequencing platforms, fluorescence quantitative PCR platform, fluorescence microscopy imaging platforms, flow cytometry platforms, new crown rapid detection reagents. The high-throughput sequencing platform includes neonatal genetic and metabolic disease genetic test "Bekekang", combined with medical pathogenic microbial targeted sequencing (tNGS), and whole exome testing products. Their products are used in the field of infectious disease prevention and control, clinical testing and eugenics.

## Funding rounds

- Series A, Nov 6, 2015 — Sangel Capital

## Investors

- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Series A